Levo uses neuroscience-based therapy to reduce a patient’s tinnitus over time. Its FDA-cleared, patented and proprietary software solution generates a customized, individualized acoustic recipe (IAR) that precisely matches the sound the patient is hearing. The patient will listen to their IAR at night for up to 8 hours throughout the 9 months of therapy to induce neuroplastic changes in the brain. Those changes will lead to a consistent and lasting tinnitus intensity reduction over time and strongly correlate with an overall improvement in quality of life.